The company engaged Apexon and its expertise in digital healthcare in 2020 to help it validate the effectiveness of a line of therapy for vision-related diseases. The project involved quality engineering related to the development of Software as a Medical Device (SaMD).
The goal was to build a companion mobile application to assist with both accurate diagnosis of vision health problems and a feedback loop to the care provider highlighting the proper line of treatment.